Evidence map›Paper›PMID 33417088›Full record

ArticleJournal of clinical immunology2021

Inherited GATA2 Deficiency Is Dominant by Haploinsufficiency and Displays Incomplete Clinical Penetrance.

Carmen Oleaga-Quintas, Edgar Borges de Oliveira-Júnior, Jérémie Rosain, Franck Rapaport, Caroline Deswarte, Antoine Guérin, Sairaj Munavar Sajjath, Yu Jerry Zhou, Stéphane Marot, Claire Lozano and 50 more

Open access · greenAbstract read
In one paragraph

Article in Journal of clinical immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 2 pooled it
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 2 syntheses or guidelines pooled it, 49 citations in OpenAlex.

  1. Pooled it
  2. Monogenic etiologies of persistent human papillomavirus infections: A comprehensive systematic review.Genetics in medicine : official journal of the American College of Medical Genetics · 2024
    Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Non-Malignant Granulocyte and Monocyte Disorders: An Update.British journal of biomedical science · 2025
    Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Inherited human ezrin deficiency impairs adaptive immunity.The Journal of allergy and clinical immunology · 2023
    Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

60 authors at 20 institutions in 10 countries.

Carmen Oleaga-QuintasLaboratory of Human Genetics of Infectious Diseases, INSERM U1163, Necker Hospital for Sick Children, 24 Boulevard du Montparnasse, Paris, France.
Edgar Borges de Oliveira-Júnior *Laboratory of Human Genetics of Infectious Diseases, INSERM U1163, Necker Hospital for Sick Children, 24 Boulevard du Montparnasse, Paris, France.
Jérémie Rosain *Laboratory of Human Genetics of Infectious Diseases, INSERM U1163, Necker Hospital for Sick Children, 24 Boulevard du Montparnasse, Paris, France.
Franck Rapaport *St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA.
Caroline Deswarte *Laboratory of Human Genetics of Infectious Diseases, INSERM U1163, Necker Hospital for Sick Children, 24 Boulevard du Montparnasse, Paris, France.
Antoine Guérin *Laboratory of Human Genetics of Infectious Diseases, INSERM U1163, Necker Hospital for Sick Children, 24 Boulevard du Montparnasse, Paris, France.
Sairaj Munavar Sajjath *Department of Microbiology and Immunology, Columbia University Medical Center, New York, NY, USA.
Yu Jerry Zhou *Department of Microbiology and Immunology, Columbia University Medical Center, New York, NY, USA.
Stéphane Marot *Center for the Study of Primary Immunodeficiencies, AP-HP, Necker Hospital for Sick Children, Paris, France.
Claire Lozano *Center for the Study of Primary Immunodeficiencies, AP-HP, Necker Hospital for Sick Children, Paris, France.
Lidia BrancoDepartment of Immunology, Porto Hospital Center, Porto, Portugal.
Nuria Fernández-HidalgoService of Infectious Diseases, University Hospital Vall d'Hebron, Barcelona, Spain.
Dukhee Betty LewThe Children's Foundation Research Center and Department of Pediatrics, College of Medicine, University of Tennessee, Memphis, TN, USA.
Anne-Sophie BrunelInfectious Diseases Unit, Montpellier, France.
Caroline ThomasPediatric Oncology and Hematology, University Hospital of Nantes, Nantes, France.
Elise LaunayPediatric Oncology and Hematology, University Hospital of Nantes, Nantes, France.
Andrés Augusto AriasSt. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA.
Alexis CuffelCenter for the Study of Primary Immunodeficiencies, AP-HP, Necker Hospital for Sick Children, Paris, France.
Vanesa Cunill MonjoDepartment of Immunology, Son Espases Hospital, Palma de Mallorca, Spain.
Anna-Lena NeehusLaboratory of Human Genetics of Infectious Diseases, INSERM U1163, Necker Hospital for Sick Children, 24 Boulevard du Montparnasse, Paris, France.
Laura MarquesDepartment of Pediatrics, Porto Hospital Center, Porto, Portugal.
Manon RoynardLaboratory of Human Genetics of Infectious Diseases, INSERM U1163, Necker Hospital for Sick Children, 24 Boulevard du Montparnasse, Paris, France.
Marcela Moncada-VélezSt. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA.
Bengü GerçekerDepartment of Dermatology, Ege University Medical Faculty, İzmir, Turkey.
Roger ColobranImmunology Division, Hospital Universitari Vall d'Hebron (HUVH), Jeffrey Model Foundation Excellence Center, Barcelona, Spain.
Marie-Gabrielle ViguéInfectious Diseases Unit, Montpellier, France.
Gabriela Lopez-HerreraImmunodeficiencies Research Unit at the National Institute of Pediatrics, Mexico City, Mexico.
Laura Berron-RuizImmunodeficiencies Research Unit at the National Institute of Pediatrics, Mexico City, Mexico.
Nora Hilda Segura MéndezAllergy and Clinical Immunology Service at the XXI Century National Medical Center, Mexican Institute of Social Security (IMSS), Mexico City, Mexico.
Patricia O'Farrill RomanillosAllergy and Clinical Immunology Service at the XXI Century National Medical Center, Mexican Institute of Social Security (IMSS), Mexico City, Mexico.
Tom Le VoyerLaboratory of Human Genetics of Infectious Diseases, INSERM U1163, Necker Hospital for Sick Children, 24 Boulevard du Montparnasse, Paris, France.
Anne PuelLaboratory of Human Genetics of Infectious Diseases, INSERM U1163, Necker Hospital for Sick Children, 24 Boulevard du Montparnasse, Paris, France.
Christine Bellanné-ChantelotDepartment of Genetics, DMU BioGeM, Pitié Salpetrière Hospital, AP-HP, Paris, France.
Kacy A RamirezThe Children's Foundation Research Center and Department of Pediatrics, College of Medicine, University of Tennessee, Memphis, TN, USA.
Lazaro Lorenzo-DiazLaboratory of Human Genetics of Infectious Diseases, INSERM U1163, Necker Hospital for Sick Children, 24 Boulevard du Montparnasse, Paris, France.
Noé Ramirez AlejoSt. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA.
Rebeca Pérez de DiegoLaboratory of Immunogenetics of Human Diseases, IdiPAZ Institute for Health Research, La Paz University Hospital, Madrid, Spain.
Antonio Condino-NetoDepartment of Immunology, Institute of Biomedical Sciences, University of Sao Paulo, Sao Paulo, SP, Brazil.
Fethi MellouliNational Center for Bone Marrow Grafts, Tunis Faculty of Medicine, University of Tunis El Manar, Tunis, Tunisia.
Carlos Rodriguez-GallegoDepartment of Immunology, Gran Canaria Dr. Negrin University Hospital, Las Palmas de Gran Canaria, Spain.
Torsten WitteClinic of Immunology and Rheumatology, Medical School of Hannover, Hannover, Germany.
José Franco RestrepoPrimary Immunodeficiencies Group, Department of Microbiology and Parasitology, School of Medicine, University of Antioquia UdeA, Medellin, Colombia.
Mariana JobimDepartment of Immunology, Clinicas Hospital of Porto Alegre, Porto Alegre, RS, Brazil.
Stéphanie Boisson-DupuisLaboratory of Human Genetics of Infectious Diseases, INSERM U1163, Necker Hospital for Sick Children, 24 Boulevard du Montparnasse, Paris, France.
Eric JeziorskiDepartment of Pediatrics, Infectious Diseases and Immunology, CHU Montpellier, Montpellier, France.
Claire FieschiDepartment of Hematology and Internal Medicine, Saint Louis Hospital, AP-HP, Paris, France.
Guillaume VogtLaboratory of Human Genetics of Infectious Diseases, INSERM U1163, Necker Hospital for Sick Children, 24 Boulevard du Montparnasse, Paris, France.
Jean DonadieuDepartment of Pediatric Hematology and Oncology, Trousseau Hospital, AP-HP, Paris, France.
Marlène PasquetDepartment of Pediatric Hematology and Immunology, CHU Toulouse, Toulouse, France.
Julia VasconcelosDepartment of Immunology, Porto Hospital Center, Porto, Portugal.
Fatma Omur ArdenizInternal Medicine Allergy and Clinical Immunology, Medical School of Ege, Izmir, Turkey.
Mónica Martínez-GalloImmunology Division, Hospital Universitari Vall d'Hebron (HUVH), Jeffrey Model Foundation Excellence Center, Barcelona, Spain.
Regis A CamposDepartment of Allergy and Clinical Immunology, Medical School, Federal University of Bahia, Salvador, BA, Brazil.
Luiz Fernando JobimDepartment of Immunology, Clinicas Hospital of Porto Alegre, Porto Alegre, RS, Brazil.
Rubén Martínez-BarricarteSt. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA.
Kang LiuDepartment of Microbiology and Immunology, Columbia University Medical Center, New York, NY, USA.
Aurélie Cobat *Laboratory of Human Genetics of Infectious Diseases, INSERM U1163, Necker Hospital for Sick Children, 24 Boulevard du Montparnasse, Paris, France.
Laurent Abel *Laboratory of Human Genetics of Infectious Diseases, INSERM U1163, Necker Hospital for Sick Children, 24 Boulevard du Montparnasse, Paris, France.
Jean-Laurent Casanova *Laboratory of Human Genetics of Infectious Diseases, INSERM U1163, Necker Hospital for Sick Children, 24 Boulevard du Montparnasse, Paris, France.
Jacinta BustamanteLaboratory of Human Genetics of Infectious Diseases, INSERM U1163, Necker Hospital for Sick Children, 24 Boulevard du Montparnasse, Paris, France. jacinta.bustamante@inserm.fr.ORCID 0000-0002-3439-2482
Inserm · FRAssistance Publique – Hôpitaux de Paris · FRRockefeller University · USColumbia University Irving Medical Center · USCUF Porto Hospital · PTCentre Hospitalier Universitaire de Nantes · FREge University · TRMexican Social Security Institute · MXSorbonne Université · FRUnité de Recherche sur les Maladies Infectieuses et Tropicales Emergentes · FRUniversidad de Antioquia · COUniversitat Autònoma de Barcelona · ESCentre Hospitalier Universitaire de Montpellier · FRHospital de Clínicas de Porto Alegre · BRHospital La Paz Institute for Health Research · ESHospital Universitario de Gran Canaria Doctor Negrín · ESHospital Universitario Son Espases · ESHoward Hughes Medical Institute · USMedizinische Hochschule Hannover · DESt. Jude Children's Research Hospital · US

Funding

Genome-Wide Dissection of Mendelian Susceptibility to Mycobacterial DiseaseR37AI095983 · NIAID · ROCKEFELLER UNIVERSITY · PI CASANOVA, JEAN-LAURENT · 2011 to 2020
$4.6M
Genome-Wide Dissection of Mendelian Susceptibility to Mycobacterial DiseaseR01AI095983 · NIAID · ROCKEFELLER UNIVERSITY · PI BUSTAMANTE, JACINTA, CASANOVA, JEAN-LAURENT · 2021 to 2025
$2.5M
NIAID NIH HHS R01 AI095983NIAID NIH HHS R37 AI095983NIH HHS R37AI095983
6 · The paper itself

Abstract

purposeGermline heterozygous mutations of GATA2 underlie a variety of hematological and clinical phenotypes. The genetic, immunological, and clinical features of GATA2-deficient patients with mycobacterial diseases in the familial context remain largely unknown.

methodsWe enrolled 15 GATA2 index cases referred for mycobacterial disease. We describe their genetic and clinical features including their relatives.

resultsWe identified 12 heterozygous GATA2 mutations, two of which had not been reported. Eight of these mutations were loss-of-function, and four were hypomorphic. None was dominant-negative in vitro, and the GATA2 locus was found to be subject to purifying selection, strongly suggesting a mechanism of haploinsufficiency. Three relatives of index cases had mycobacterial disease and were also heterozygous, resulting in 18 patients in total. Mycobacterial infection was the first clinical manifestation in 11 patients, at a mean age of 22.5 years (range: 12 to 42 years). Most patients also suffered from other infections, monocytopenia, or myelodysplasia. Strikingly, the clinical penetrance was incomplete (32.9% by age 40 years), as 16 heterozygous relatives aged between 6 and 78 years, including 4 older than 60 years, were completely asymptomatic.

conclusionClinical penetrance for mycobacterial disease was found to be similar to other GATA2 deficiency-related manifestations. These observations suggest that other mechanisms contribute to the phenotypic expression of GATA2 deficiency. A diagnosis of autosomal dominant GATA2 deficiency should be considered in patients with mycobacterial infections and/or other GATA2 deficiency-related phenotypes at any age in life. Moreover, all direct relatives should be genotyped at the GATA2 locus.

Indexed as

Genetic Association StudiesGenetic Predisposition to DiseaseHaploinsufficiencyPenetrancePhenotypeAdolescentAdultAllelesCell LineChildDatabases, GeneticDNA Mutational AnalysisExome SequencingFemaleGATA2 DeficiencyGenes, DominantGATA2haploinsufficiencymycobacteriaPrimary immunodeficiencytuberculosis

Identifiers

PMID33417088
PMCPMC8938944
OpenAlexW3120175537

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.